These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18519539)

  • 41. Varenicline induced mania in a 51 year old patient without history of bipolar illness.
    Hussain S; Kayne E; Guwanardane N; Petrides G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1162-3. PubMed ID: 21396974
    [No Abstract]   [Full Text] [Related]  

  • 42. Varenicline (champix)-associated manic relapse in bipolar affective disorder.
    MacSuibhne S; Giwa TA; McCauley MD
    Ir Med J; 2010 Oct; 103(9):286. PubMed ID: 21186758
    [No Abstract]   [Full Text] [Related]  

  • 43. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
    Faessel HM; Smith BJ; Gibbs MA; Gobey JS; Clark DJ; Burstein AH
    J Clin Pharmacol; 2006 Sep; 46(9):991-8. PubMed ID: 16920893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
    O'Malley SS
    Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436
    [No Abstract]   [Full Text] [Related]  

  • 45. Varenicline induces manic relapse in bipolar disorder.
    Knibbs N; Tsoi DT
    Gen Hosp Psychiatry; 2011; 33(6):641.e1-2. PubMed ID: 21749843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute generalized exanthematous pustulosis caused by varenicline.
    Duparc A; Gosset P; Caron J; Lasek A; Modiano P
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1111-2. PubMed ID: 19175479
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduced affective symptoms during tobacco dependence treatment with varenicline.
    Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A
    Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoking cessation in patients with chronic kidney disease.
    Raymond CB; Naylor HK
    CANNT J; 2010; 20(4):24-9; quiz 30-1. PubMed ID: 21319580
    [No Abstract]   [Full Text] [Related]  

  • 49. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varenicline reduced smoking behaviour in a mentally ill person.
    Ochoa EL
    J Psychopharmacol; 2009 May; 23(3):340-1. PubMed ID: 18562426
    [No Abstract]   [Full Text] [Related]  

  • 53. Varenicline: aggression and homicidal ideation.
    Prescrire Int; 2012 Feb; 21(124):42-3. PubMed ID: 22413719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic review wins CMAJ Bruce Squires Award.
    Bawagan J
    CMAJ; 2013 May; 185(8):643. PubMed ID: 23549976
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 56. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
    Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119
    [No Abstract]   [Full Text] [Related]  

  • 57. Varenicline efficacy and tolerability in a subject with schizophrenia.
    Fatemi SH
    Schizophr Res; 2008 Aug; 103(1-3):328-9. PubMed ID: 18572388
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.
    Burstein AH; Fullerton T; Clark DJ; Faessel HM
    J Clin Pharmacol; 2006 Nov; 46(11):1234-40. PubMed ID: 17050788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thoughts and acts of aggression/violence toward others reported in association with varenicline.
    Moore TJ; Glenmullen J; Furberg CD
    Ann Pharmacother; 2010 Sep; 44(9):1389-94. PubMed ID: 20647416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
    Faessel HM; Gibbs MA; Clark DJ; Rohrbacher K; Stolar M; Burstein AH
    J Clin Pharmacol; 2006 Dec; 46(12):1439-48. PubMed ID: 17101743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.